Wearable Infusion Pumps Market Report 2024

This Wearable Infusion Pumps market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The wearable infusion pumps market size has grown strongly in recent years. It will grow from $1.25 billion in 2023 to $1.37 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, an aging population, higher global healthcare spending, greater awareness and education, and advancements in drug formulations.

The wearable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth during the forecast period can be attributed to the rise in chronic diseases, an expanding global aging population, increasing patient preference for minimally invasive treatment options, and the development and improvement of healthcare infrastructure in emerging markets. Key trends expected in this period include the integration of advanced technologies, the development of smaller, more discreet devices, customizable infusion settings and dosage adjustments, as well as enhanced data analytics.

The growing prevalence of chronic diseases is expected to drive the expansion of the wearable infusion pump market in the future. Chronic diseases are long-term health conditions that typically progress slowly and last for a year or more, often requiring continuous medical care. Some common chronic diseases include cancer, heart disease, diabetes, and arthritis. The rise in chronic diseases is attributed to a mix of genetic, environmental, and lifestyle factors, such as poor diet, lack of physical activity, and exposure to toxins. Wearable infusion pumps assist patients with chronic conditions by delivering medications continuously and accurately, improving treatment adherence, and optimizing care. For example, in June 2024, the National Health Service (NHS) in England reported that 3,615,330 people were registered with a GP for non-diabetic hyperglycemia (pre-diabetes) in 2023, marking an 18% increase from the previous year's 3,065,825. This growth highlights a significant rise in pre-diabetes cases. Consequently, the increasing prevalence of chronic diseases is set to boost the wearable infusion pump market.

Leading companies in the wearable infusion pump market are focusing on the development of advanced products, such as tubeless, wearable, and disposable insulin pumps, to enhance user convenience, improve adherence to treatment, and provide more efficient and discreet insulin delivery options for diabetes management. These pumps are small, skin-adhered devices that offer continuous insulin delivery without the need for external tubes and are replaced after a set period. For example, in February 2023, GulfDrug LLC, a UAE-based healthcare company, introduced EOPatch, an innovative tubeless, wearable, and disposable insulin pump that can be controlled via Android and iOS smartphones using the Narsha app. EOPatch offers up to 84 hours of continuous insulin delivery, simplifying the replacement cycle to twice a week, and can communicate with certain blood glucose meters via Bluetooth. The Narsha app, the first smartphone application approved for this purpose, combines insulin delivery control with diabetes data management, eliminating the need for a separate controller.

In June 2023, Lohmann Therapie-Systeme AG (LTS), a Germany-based drug delivery system company, acquired Sorrel from Eitan Medical for $100 million. This acquisition aims to expand LTS's portfolio of drug delivery systems by integrating Sorrel, a subsidiary of Eitan Medical, which is a drug delivery platform that includes wearable pumps. Eitan Medical, an Israel-based company, specializes in innovative infusion and drug delivery solutions, including wearable infusion pumps such as patient-controlled epidural analgesia, with a focus on enhancing patient care through advanced medical technology.

Major companies operating in the wearable infusion pumps market are Fresenius SE & Co. KGaA, Medtronic Plc, Medline Industries Inc., Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, ICU Medical Inc., Insulet Corporation, Sorenson Medical, Avanos Medical Inc., Vygon SA, pfm medical GmbH, Eitan Medical, Micrel Medical Devices SA, Zyno Medical LLC, Q-Core Medical Ltd., Epic Medical Solutions, MOOG Inc., Smiths Medical International Ltd.

North America was the largest region in the wearable infusion pump market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the wearable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A wearable infusion pump is a portable medical device designed to deliver precise doses of medication or fluids over an extended period. Typically worn on the body, it provides either continuous or intermittent infusion, offering patients both convenience and flexibility.

The primary types of wearable infusion pumps include electronic ambulatory infusion pumps, patient-controlled analgesia (PCA) pumps, large-volume pumps, syringe pumps, and others. Electronic ambulatory infusion pumps are portable devices that use electronic controls to administer medication continuously with precision. These pumps can be disposable or reusable and are used for various applications, including diabetes management, antibiotic infusions, chemotherapy, pain management, Parkinson's disease, and more.

The wearable infusion pumps market research report is one of a series of new reports that provides wearable infusion pumps market statistics, including wearable infusion pumps industry global market size, regional shares, competitors with a wearable infusion pumps market share, detailed wearable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the wearable infusion pumps industry. This wearable infusion pumps market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The wearable infusion pump market consists of sales of infusion sets, reservoirs, and adhesive patches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.